IMRIS Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IMRSQ research report →
About the company
Based in Winnipeg, Canada, and established in 2005, IMRIS Inc. is a global leader in developing, producing, and distributing advanced image-guided therapy solutions. The company's flagship offering is the VISIUS Surgical Theatre, a sophisticated operating room environment.
- CEO
- Shalabh Chandra
- IPO
- 2023
- Employees
- 121
- HQ
- CA
Price Chart
- Market Cap
- $626
- P/E
- -0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -0.81
- Div Yield
- 0.00%
- Gross Margin
- 34.38%
- Op Margin
- -80.09%
- Net Margin
- -105.18%
- ROE
- -129.83%
- ROIC
- -63.89%
- Revenue
- $28.89M · -37.25%
- Net Income
- $-30,387,000 · 27.65%
- EPS
- $-0.58 · 30.12%
- Op Income
- $-23,140,000
- FCF YoY
- 72.87%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 7.79
- Avg Volume
- 24.14K
Get TickerSpark's AI analysis on IMRSQ
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our IMRSQ coverage
Recent articles, reports, and earnings notes.
No research on IMRSQ yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IMRSQ report →Similar companies
Peers in the same neighborhood.